C. Gomez

Lack of ability of ciprofloxacin-rifampin prophylaxis to decrease infection-related morbidity in neutropenic patients given cytotoxic therapy and peripheral blood stem cell transplants

M. Hidalgo, R. Hitt, C. Lumbreras, 1997, Antimicrobial agents and chemotherapy.

Granulocyte colony-stimulating factor in the treatment of high-risk febrile neutropenia: a multicenter randomized trial.

A. Tres, J. Mayordomo, V. Guillem, 2001, Journal of the National Cancer Institute.

Immune biomarkers to predict SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies

F. Prósper, B. Paiva, J. San-Miguel, 2021, Blood Cancer Journal.

Incidence and clinical impact of fluoroquinolone-resistant Escherichia coli in the faecal flora of cancer patients treated with high dose chemotherapy and ciprofloxacin prophylaxis.

M. Hidalgo, D. Folgueira, C. Lumbreras, 1999, The Journal of antimicrobial chemotherapy.

Circulating tumor and immune cells for minimally invasive risk stratification of smoldering multiple myeloma.

H. Goldschmidt, F. Prósper, A. Órfão, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Ultra-Sensitive Assessment of Measurable Residual Disease (MRD) in Peripheral Blood (PB) of Multiple Myeloma (MM) Patients Using Bloodflow

A. Órfão, N. Puig, J. Flores-Montero, 2022, Blood.

Methylprednisolone added to tocilizumab reduces mortality in SARS-CoV-2 pneumonia: An observational study.

P. García, M. G. Deltoro, F. Herrero, 2020 .